1. Home
  2. AREN vs ADAP Comparison

AREN vs ADAP Comparison

Compare AREN & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • ADAP
  • Stock Information
  • Founded
  • AREN 2016
  • ADAP 2008
  • Country
  • AREN United States
  • ADAP United Kingdom
  • Employees
  • AREN N/A
  • ADAP N/A
  • Industry
  • AREN Medical/Dental Instruments
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • ADAP Health Care
  • Exchange
  • AREN Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • AREN 64.1M
  • ADAP 71.6M
  • IPO Year
  • AREN N/A
  • ADAP 2015
  • Fundamental
  • Price
  • AREN $1.96
  • ADAP $0.25
  • Analyst Decision
  • AREN
  • ADAP Strong Buy
  • Analyst Count
  • AREN 0
  • ADAP 5
  • Target Price
  • AREN N/A
  • ADAP $1.83
  • AVG Volume (30 Days)
  • AREN 38.8K
  • ADAP 3.1M
  • Earning Date
  • AREN 05-16-2025
  • ADAP 05-14-2025
  • Dividend Yield
  • AREN N/A
  • ADAP N/A
  • EPS Growth
  • AREN N/A
  • ADAP N/A
  • EPS
  • AREN N/A
  • ADAP N/A
  • Revenue
  • AREN $234,396,000.00
  • ADAP $178,032,000.00
  • Revenue This Year
  • AREN $12.73
  • ADAP N/A
  • Revenue Next Year
  • AREN $71.95
  • ADAP $64.04
  • P/E Ratio
  • AREN N/A
  • ADAP N/A
  • Revenue Growth
  • AREN 45.45
  • ADAP 195.34
  • 52 Week Low
  • AREN $0.56
  • ADAP $0.20
  • 52 Week High
  • AREN $2.18
  • ADAP $1.48
  • Technical
  • Relative Strength Index (RSI)
  • AREN 71.42
  • ADAP 40.58
  • Support Level
  • AREN $1.46
  • ADAP $0.20
  • Resistance Level
  • AREN $1.99
  • ADAP $0.33
  • Average True Range (ATR)
  • AREN 0.14
  • ADAP 0.05
  • MACD
  • AREN 0.03
  • ADAP 0.01
  • Stochastic Oscillator
  • AREN 100.00
  • ADAP 40.33

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Share on Social Networks: